1 |
Sautès-Fridman C, Cherfils-Vicini J, Damotte D, et al.Tumor microenvironment is multifaceted [J]. Cancer Metastasis Rev, 2011, 30(1): 13-25.
|
2 |
Whiteside TL. The tumor microenvironment and its role in promoting tumor growth [J]. Oncogene, 2008, 27(45): 5904-5912.
|
3 |
Fokas E, McKenna WG, Muschel RJ. The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies [J]. Cancer Metastasis Rev, 2012, 31(3-4): 823-842.
|
4 |
Nguyen L, Fifis T, Christophi C. Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis [J]. BMC Cancer, 2016, 16: 533.
|
5 |
Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention [J]. Nat Rev Cancer, 2007, 7(2): 139-147.
|
6 |
Fang H, Declerck YA. Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials [J]. Cancer Res, 2013, 73(16): 4965-4977.
|
7 |
Miyazaki Y, Shibuya M, Sugawara H, et al. Salinomycin,a new polyether antibiotic [J]. J Antibiot (Tokyo), 1974, 27(11): 814-821.
|
8 |
Gupta PB, Onder TT, Jiang G, et al. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening [J]. Cell, 2009, 138(4): 645-659.
|
9 |
Li T, Liu X, Shen Q, et al. Salinomycin exerts anti-angiogenic and anti-tumorigenic activities byinhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis [J]. Oncotarget, 2016, 7(18): 26580-26592.
|
10 |
Bello L, Giussani C, Carrabba G, et al. Angiogenesis and invasion in gliomas [J]. Cancer Treat Res, 2004, 117: 263-284.
|
11 |
Tate MC, Aghi MK. Biology of Angiogenesis and Invasion in Glioma [J]. Neurotherapeutics, 2009, 6(3): 447-457.
|
12 |
Tepper OM, Galiano RD, Kalka C, et al. Endothelial Progenitor Cells: The Promise of Vascular Stem Cells for Plastic Surgery [J]. Plast Reconstr Surg, 2003, 111(2): 846-854.
|
13 |
Li WD, Li XQ. Endothelial progenitor cells accelerate the resolution of deep vein thrombosis [J]. Vascul Pharmacol, 2016, 83: 10-16.
|
14 |
Grapensparr L, Olerud J, Vasylovska S, et al. The therapeutic role of endothelial progenitor cells in Type 1 diabetes mellitus [J]. Regen Med, 2011, 6(5): 599-605.
|
15 |
Li DW, Liu ZQ, Wei J, et al. Contribution of endothelial progenitor cells to neovascularization (Review) [J]. Int J Mol Med, 2012, 30(5): 1000-1006.
|
16 |
Kerbel RS. Tumor angiogenesis [J]. N Engl J Med, 2008, 358(19): 2039-2049.
|
17 |
He L, Wang F, Dai WQ, et al. Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines [J]. Pancreatology, 2013, 13(1): 72-78.
|
18 |
Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets [J]. Nat Med, 2011, 17(11): 1359-1370.
|